INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,000 | -98.2% | 474 | -98.5% | 0.00% | -100.0% |
| Q3 2017 | $274,000 | -33.5% | 30,800 | -21.4% | 0.00% | -66.7% |
| Q1 2017 | $412,000 | -11.0% | 39,200 | -22.1% | 0.00% | 0.0% |
| Q4 2016 | $463,000 | +7616.7% | 50,300 | +9960.0% | 0.00% | – |
| Q3 2016 | $6,000 | +500.0% | 500 | +1251.4% | 0.00% | – |
| Q3 2015 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |